Enochian Biosciences Inc
0.0 %
-81.86 %
Yet to be announced
Company Overview
Enochian Biosciences Inc is a biotechnology company focused on developing novel gene-modified cellular and immune therapies for potentially life-threatening diseases. The company is primarily engaged in research and development activities, with a focus on treatments for HIV, cancer, and other serious conditions.
Revenue Sources
As a pre-revenue biotechnology company still in research and development phase with no revenue reported in the last four quarters, this criterion is not applicable at this stage of the company's development.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
The company reported interest expenses in all four quarters but is still in pre-revenue R&D phase. When a company is pre-revenue and primarily focused on research and development, interest expense analysis is not applicable as the company hasn't reached its mature operational stage.
Operational Ethics
Based on available SEC filings and company information, there is no evidence of significant ongoing associations with entities involved in human rights violations such as the state of Israel or the Chinese Communist Party.
Login to join the discussion